WHO ICTRP trial
The appearance of blackcurrant compounds and the inhibition of MAO-B enzyme…
ACTRN12624000929505 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12624000929505 |
|---|---|
| Public title | The appearance of blackcurrant compounds and the inhibition of MAO-B enzyme activity in blood after consuming a single dose of two different blackcurrant beverages in healthy adults |
| Scientific title | Characterising the effect of blackcurrant beverage format on the bioavailability of blackcurrant phytochemicals and platelet MAO-B enzyme activity in healthy adults |
| Primary sponsor | Dr Jocelyn Eason - New Zealand Institute for Plant & Food Research |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | New Zealand |
| Conditions | MAO-B enzyme inhibition; MAO-B enzyme inhibition;Neurological - Studies of the normal brain and nervous system |
| Interventions | This study will investigate the effect of food format (freeze dried powder or juice concentrate) on inhibiting platelet monoamine oxidase-B activity and bioavailability of blackcurrant anthocyanins and sarmentosin. We will implement a… |
| Registration date | Jan 8, 2024 |
| Target size | 12 |
| Registry page | anzctr.org.au |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: